Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 104

Similar articles for PubMed (Select 21059932)

1.

Plant-derived human butyrylcholinesterase, but not an organophosphorous-compound hydrolyzing variant thereof, protects rodents against nerve agents.

Geyer BC, Kannan L, Garnaud PE, Broomfield CA, Cadieux CL, Cherni I, Hodgins SM, Kasten SA, Kelley K, Kilbourne J, Oliver ZP, Otto TC, Puffenberger I, Reeves TE, Robbins N 2nd, Woods RR, Soreq H, Lenz DE, Cerasoli DM, Mor TS.

Proc Natl Acad Sci U S A. 2010 Nov 23;107(47):20251-6. doi: 10.1073/pnas.1009021107. Epub 2010 Nov 8.

2.

In search of a catalytic bioscavenger for the prophylaxis of nerve agent toxicity.

diTargiani RC, Chandrasekaran L, Belinskaya T, Saxena A.

Chem Biol Interact. 2010 Sep 6;187(1-3):349-54. doi: 10.1016/j.cbi.2010.02.021. Epub 2010 Feb 20.

PMID:
20176006
3.

Prophylaxis and post-exposure treatment of intoxications caused by nerve agents and organophosphorus pesticides.

Kuca K, Jun D, Musilek K, Pohanka M, Karasova JZ, Soukup O.

Mini Rev Med Chem. 2013 Dec;13(14):2102-15.

PMID:
24195661
4.

Comparison of polyethylene glycol-conjugated recombinant human acetylcholinesterase and serum human butyrylcholinesterase as bioscavengers of organophosphate compounds.

Cohen O, Kronman C, Raveh L, Mazor O, Ordentlich A, Shafferman A.

Mol Pharmacol. 2006 Sep;70(3):1121-31. Epub 2006 Jun 26.

5.

Bioscavengers for the protection of humans against organophosphate toxicity.

Doctor BP, Saxena A.

Chem Biol Interact. 2005 Dec 15;157-158:167-71. Epub 2005 Nov 15.

PMID:
16293236
6.

Demonstration of in vivo stability and lack of immunogenicity of a polyethyleneglycol-conjugated recombinant CHO-derived butyrylcholinesterase bioscavenger using a homologous macaque model.

Rosenberg YJ, Saxena A, Sun W, Jiang X, Chilukuri N, Luo C, Doctor BP, Lee KD.

Chem Biol Interact. 2010 Sep 6;187(1-3):279-86. doi: 10.1016/j.cbi.2010.02.042. Epub 2010 Mar 6.

PMID:
20211615
7.

Progress in the development of enzyme-based nerve agent bioscavengers.

Nachon F, Brazzolotto X, Trovaslet M, Masson P.

Chem Biol Interact. 2013 Dec 5;206(3):536-44. doi: 10.1016/j.cbi.2013.06.012. Epub 2013 Jun 26. Review.

PMID:
23811386
8.

Organophosphates, serine esterase inhibition, and modeling of organophosphate toxicity.

Chambers J, Oppenheimer SF.

Toxicol Sci. 2004 Feb;77(2):185-7.

9.

Identification of human butyrylcholinesterase organophosphate-resistant variants through a novel mammalian enzyme functional screen.

Zhang J, Chen S, Ralph EC, Dwyer M, Cashman JR.

J Pharmacol Exp Ther. 2012 Dec;343(3):673-82. doi: 10.1124/jpet.112.198499. Epub 2012 Sep 6.

10.

Blood acylpeptide hydrolase activity is a sensitive marker for exposure to some organophosphate toxicants.

Quistad GB, Klintenberg R, Casida JE.

Toxicol Sci. 2005 Aug;86(2):291-9. Epub 2005 May 11.

11.

Chemical polysialylation of human recombinant butyrylcholinesterase delivers a long-acting bioscavenger for nerve agents in vivo.

Ilyushin DG, Smirnov IV, Belogurov AA Jr, Dyachenko IA, Zharmukhamedova TIu, Novozhilova TI, Bychikhin EA, Serebryakova MV, Kharybin ON, Murashev AN, Anikienko KA, Nikolaev EN, Ponomarenko NA, Genkin DD, Blackburn GM, Masson P, Gabibov AG.

Proc Natl Acad Sci U S A. 2013 Jan 22;110(4):1243-8. doi: 10.1073/pnas.1211118110. Epub 2013 Jan 7.

12.

Stoichiometric and catalytic scavengers as protection against nerve agent toxicity: a mini review.

Lenz DE, Yeung D, Smith JR, Sweeney RE, Lumley LA, Cerasoli DM.

Toxicology. 2007 Apr 20;233(1-3):31-9. Epub 2006 Dec 1. Review.

PMID:
17188793
13.

Prophylaxis with human serum butyrylcholinesterase protects guinea pigs exposed to multiple lethal doses of soman or VX.

Saxena A, Sun W, Fedorko JM, Koplovitz I, Doctor BP.

Biochem Pharmacol. 2011 Jan 1;81(1):164-9. doi: 10.1016/j.bcp.2010.09.007. Epub 2010 Sep 21.

PMID:
20846507
14.

Transgenic plants as a source for the bioscavenging enzyme, human butyrylcholinesterase.

Geyer BC, Kannan L, Cherni I, Woods RR, Soreq H, Mor TS.

Plant Biotechnol J. 2010 Oct;8(8):873-86. doi: 10.1111/j.1467-7652.2010.00515.x.

PMID:
20353404
15.

Chemical biology: Catalytic detoxification.

Raushel FM.

Nature. 2011 Jan 20;469(7330):310-1. doi: 10.1038/469310a. No abstract available.

PMID:
21248836
17.

His-tag truncated butyrylcholinesterase as a useful construct for in vitro characterization of wild-type and variant butyrylcholinesterases.

Ralph EC, Xiang L, Cashman JR, Zhang J.

Protein Expr Purif. 2011 Nov;80(1):22-7. doi: 10.1016/j.pep.2011.07.005. Epub 2011 Jul 23.

18.

Assessing protection against OP pesticides and nerve agents provided by wild-type HuPON1 purified from Trichoplusia ni larvae or induced via adenoviral infection.

Hodgins SM, Kasten SA, Harrison J, Otto TC, Oliver ZP, Rezk P, Reeves TE, Chilukuri N, Cerasoli DM.

Chem Biol Interact. 2013 Mar 25;203(1):177-80. doi: 10.1016/j.cbi.2012.10.015. Epub 2012 Nov 2.

PMID:
23123254
19.

Resistance to organophosphorus agent toxicity in transgenic mice expressing the G117H mutant of human butyrylcholinesterase.

Wang Y, Boeck AT, Duysen EG, Van Keuren M, Saunders TL, Lockridge O.

Toxicol Appl Pharmacol. 2004 May 1;196(3):356-66.

PMID:
15094306
20.

Butyrylcholinesterase as a therapeutic drug for protection against percutaneous VX.

Lenz DE, Clarkson ED, Schulz SM, Cerasoli DM.

Chem Biol Interact. 2010 Sep 6;187(1-3):249-52. doi: 10.1016/j.cbi.2010.05.014. Epub 2010 Jun 1.

PMID:
20513442
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk